Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of the blood pressure
medication, aliskiren, in heart transplant patients. In terms of safety, the investigators
will evaluate the blood levels of aliskiren and determine if aliskiren alters the blood
levels of the anti-rejection medication, cyclosporine, in these patients. In terms of
efficacy, the investigators will determine how well aliskiren lowers blood pressure in heart
transplant patients.